9 February 2021
22 July 2020
READ MOREAkston Biosciences Receives $2.5M Milestone Payment
9 April 2020
READ MOREAkston Biosciences Completes Series E Preferred Stock Financing
2 August 2019
READ MOREAkston Biosciences Completes Licensing and Supply Agreement with Dechra Pharmaceuticals PLC
26 May 2019
READ MOREAkston Biosciences Begins Buildout of New GMP Biologics Manufacturing Facility
10 May 2019
READ MOREAkston Biosciences Completes Convertible Note Financing
17 May 2018
READ MOREAkston Biosciences Completes Series D Preferred Stock Financing
8 March 2023
READ MOREAkston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA
1 November 2022
READ MOREAkston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial
9 August 2022